Thrombolysis for concomitant acute stroke and pulmonary embolism

Journal of Clinical Neuroscience

Volumn 15, Issue 8, 2008, Pages 917-920

  Allport, Louise E ^a   Butcher, Ken S ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Embolic stroke; Ischaemic stroke; Pulmonary embolism; Thrombolysis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; ARTICLE; BRAIN INFARCTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG EFFICACY; DRUG INDICATION; DYSPNEA; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

FEMALE; HUMANS; MIDDLE AGED; PULMONARY EMBOLISM; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 45849096451     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.03.026     Document Type: Article

References (10)

1. Adams H.P., Brott T.G., Furlan A.J., et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 27 (1996) 1711-1718
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-7.
3. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274 (1995) 1017-1025
4. Demchuk A.M., Hill M.D., Barber P.A., et al. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 36 (2005) 2110-2115
5. Goldhaber S.Z. Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue. Circulation 104 (2001) 2876-2878
6. Thomas M.D., Chauhan A., and More R.S. Pulmonary embolism-an update on thrombolytic therapy. QJM 93 (2000) 261-267
7. Donnan G.A., and Davis S.M. Heparin in stroke: not for most, but the controversy lingers. Stroke 34 (2003) 232-233
8. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;349:1569-81.
9. Camerlingo M., Salvi P., Belloni G., et al. Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke 36 (2005) 2415-2420
10. Caplan L.R. Resolved: heparin may be useful in selected patients with brain ischemia. Stroke 34 (2003) 230-231